Alfred Asante-Korang, MD

Dr. Goldenberg is a Professor of Pediatrics and Medicine, Divisions of Hematology, at the Johns Hopkins University School of Medicine and the Perry Family Professor of Clinical and Translational Research. He is also the associate dean for research at Johns Hopkins All Children's Hospital, chief research officer of the Johns Hopkins All Children's Hospital Research Institute, and director of the Johns Hopkins All Children's Institute for Clinical and Translational Research. Additionally, Dr. Goldenberg co-directs a Data Coordinating Center for Pediatric Multicenter Studies and a pediatric-focused Translational Research and Innovation Laboratory, both based on the Johns Hopkins All Children’s campus. The research that Dr. Goldenberg leads focuses on thrombosis and stroke in children and young adults and has been published in top-tier medical/scientific journals, including the New England Journal of Medicine and the Journal of the American Medical Association. He serves as Overall Principal Investigator for a recently completed National Institutes of Health (NIH) U01-sponsored multinational randomized clinical trial on the duration of anticoagulant therapy for venous thromboembolism in patients less than 21 years of age. Presently, he holds a K24 mentoring award in clinical and translational research in pediatric thrombosis through the NIH. After receiving his medical degree from McGill University Faculty of Medicine in Montréal, Dr. Goldenberg completed his internship and residency at the University of South Florida College of Medicine as a member of the inaugural class of the combined residency program in internal medicine and pediatrics. He performed a fellowship in pediatric hematology/oncology/bone marrow transplantation at The Children's Hospital, Denver (now Children's Hospital Colorado), and the University of Colorado Health Sciences Center, where he also earned a Ph.D. in clinical investigation. Prior to joining Johns Hopkins in 2012, Dr. Goldenberg was on the faculty of the University of Colorado School of Medicine and served as director of the Children's Clinical Research Organization and co-director of the Pediatric Thrombosis and Stroke Programs at Children's Hospital Colorado. He also served as director of the Department of Clinical Science and Safety at CPC Clinical Research, a non-profit clinical trials management organization affiliated with the University of Colorado, after having served as director of Clinical Research for the Mountain States Regional Hemophilia and Thrombosis Center. Dr. Goldenberg received the Eberhard E. Mammen Award for Excellence in Hemostasis and Thrombosis in 2012. He is the immediate past chair of the Pediatric Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, a member of the Clinical Trials Subcommittee of the American Society of Hematology and the Pediatric Clinical Trials Working Group of the NIH Clinical and Translational Science Award network, and an associate editor of the journal Seminars in Thrombosis and Hemostasis. Dr. Goldenberg speaks nationally and internationally on thrombosis, stroke, coagulation science, clinical and translational research methodology, and innovative clinical trial designs.

Dr. Szymanski specializes in pediatric rheumatology at Johns Hopkins All Children’s. She sees patients at the hospital’s main campus in St. Petersburg, Florida, and the Outpatient Care Center in Tampa. She joined the hospital staff in 2019. Dr. Szymanski earned her doctorate from the University of Miami Miller School of Medicine. She completed an internship and residency in the Department of Pediatrics at Children’s National Health System in Washington, D.C. She then completed a fellowship in pediatric rheumatology at Children’s National Health System and National Institutes of Health in Bethesda, Maryland. She is interested in advocacy for rheumatological patients and currently serves as the Medical Chair for Tampa Bay Leadership Board for the Arthritis Foundation.